Equities Research Analysts’ updated eps estimates for Thursday, September 14th:

Applied Genetic Technologies Corporation (NASDAQ:AGTC) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $8.00 target price on the stock, down from their previous target price of $16.00.

Amarin Corporation PLC (NASDAQ:AMRN) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $10.00 price target on the stock.

Argonaut Gold (TSE:AR) had its hold rating reiterated by analysts at Laurentian Bank of Canada. The firm currently has a C$2.50 price target on the stock.

Broadcom Limited (NASDAQ:AVGO) had its overweight rating reissued by analysts at KeyCorp.

Axovant Sciences (NYSE:AXON) had its sell rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $8.00 target price on the stock.

C.R. Bard (NYSE:BCR) had its hold rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $317.00 price target on the stock.

Bellicum Pharmaceuticals (NASDAQ:BLCM) had its buy rating reissued by analysts at Jefferies Group LLC. The firm currently has a $16.00 price target on the stock.

Bemis (NYSE:BMS) had its hold rating reissued by analysts at SunTrust Banks, Inc.. The firm currently has a $47.00 target price on the stock, down from their previous target price of $49.00.

Coca-Cola European Partners PLC (NYSE:CCE) had its hold rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $45.00 target price on the stock.

Cempra (NASDAQ:CEMP) had its hold rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $3.00 price target on the stock.

Cirrus Logic (NASDAQ:CRUS) had its overweight rating reaffirmed by analysts at KeyCorp.

Cypress Semiconductor Corporation (NASDAQ:CY) had its overweight rating reiterated by analysts at KeyCorp.

Dick’s Sporting Goods (NYSE:DKS) had its outperform rating reissued by analysts at BMO Capital Markets.

Dolby Laboratories (NYSE:DLB) had its buy rating reaffirmed by analysts at B. Riley. B. Riley currently has a $61.50 price target on the stock.

FibroGen (NASDAQ:FGEN) had its buy rating reissued by analysts at Stifel Nicolaus. They currently have a $80.00 price target on the stock.

Fitbit (NYSE:FIT) had its hold rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $6.00 target price on the stock.

Amicus Therapeutics (NASDAQ:FOLD) had its outperform rating reissued by analysts at Cowen and Company. Cowen and Company currently has a $18.00 price target on the stock, up from their previous price target of $16.00.

Genomic Health (NASDAQ:GHDX) had its hold rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $33.00 price target on the stock.

GMV Minerals (TSE:GMV) had its buy rating reaffirmed by analysts at Fundamental Research. The firm currently has a C$1.63 price target on the stock.

Intercept Pharmaceuticals (NASDAQ:ICPT) had its outperform rating reiterated by analysts at Cowen and Company. They currently have a $232.00 price target on the stock.

Intercept Pharmaceuticals (NASDAQ:ICPT) had its outperform rating reiterated by analysts at Oppenheimer Holdings, Inc.. Oppenheimer Holdings, Inc. currently has a $200.00 price target on the stock.

Integrated Device Technology (NASDAQ:IDTI) had its overweight rating reaffirmed by analysts at KeyCorp.

Intel Corporation (NASDAQ:INTC) had its overweight rating reaffirmed by analysts at J P Morgan Chase & Co.

iRobot Corporation (NASDAQ:IRBT) had its sell rating reaffirmed by analysts at SprucePoint Capital.

J.C. Penney Company, Inc. Holding (NYSE:JCP) had its hold rating reissued by analysts at Jefferies Group LLC. They currently have a $4.00 price target on the stock.

Canada Jetlines (TSE:JET) had its buy rating reissued by analysts at Fundamental Research. They currently have a C$3.03 price target on the stock.

Nordstrom (NYSE:JWN) had its overweight rating reaffirmed by analysts at KeyCorp. They currently have a $55.00 price target on the stock.

Lumentum Holdings (NASDAQ:LITE) had its overweight rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $68.00 price target on the stock.

Lumentum Holdings (NASDAQ:LITE) had its buy rating reaffirmed by analysts at B. Riley. B. Riley currently has a $81.00 target price on the stock.

Macy’s (NYSE:M) had its outperform rating reissued by analysts at BMO Capital Markets.

The Medicines (NASDAQ:MDCO) had its buy rating reissued by analysts at Jefferies Group LLC. The firm currently has a $54.00 price target on the stock.

Keefe, Bruyette & Woods started coverage on shares of Nidec (NYSE:NJ). Keefe, Bruyette & Woods issued an outperform rating and a $14.00 target price on the stock.

Nike (NYSE:NKE) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $69.00 price target on the stock.

Nutanix (NASDAQ:NTNX) had its overweight rating reiterated by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $28.00 price target on the stock.

Organovo Holdings (NASDAQ:ONVO) had its buy rating reissued by analysts at Jefferies Group LLC. The firm currently has a $4.00 price target on the stock.

IMPINJ (NYSE:PI) had its buy rating reaffirmed by analysts at Dougherty & Co. They currently have a $62.00 target price on the stock.

Qorvo (NASDAQ:QRVO) had its sector perform rating reissued by analysts at KeyCorp.

Rexford Industrial Realty (NASDAQ:REXR) had its buy rating reiterated by analysts at Stifel Nicolaus. They currently have a $33.00 target price on the stock, up from their previous target price of $30.00.

Repligen Corporation (NASDAQ:RGEN) had its hold rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $40.00 price target on the stock.

Sealed Air Corporation (NYSE:SEE) had its hold rating reissued by analysts at Jefferies Group LLC. The firm currently has a $44.00 price target on the stock.

Seattle Genetics (NASDAQ:SGEN) had its buy rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $53.00 price target on the stock.

Sangamo Therapeutics (NASDAQ:SGMO) had its buy rating reiterated by analysts at Jefferies Group LLC. They currently have a $18.00 target price on the stock.

Snap (NYSE:SNAP) had its buy rating reissued by analysts at Drexel Hamilton. Drexel Hamilton currently has a $30.00 target price on the stock. The analysts wrote, “We continue to believe Snap has strong upside potential over the next 12 months as reflected in our $30.00 price target.””

Sarepta Therapeutics (NASDAQ:SRPT) had its outperform rating reissued by analysts at Cowen and Company. Cowen and Company currently has a $69.00 price target on the stock.

Skyworks Solutions (NASDAQ:SWKS) had its overweight rating reissued by analysts at KeyCorp.

Synaptics (NASDAQ:SYNA) had its overweight rating reiterated by analysts at KeyCorp.

Synaptics (NASDAQ:SYNA) had its underperform rating reiterated by analysts at Oppenheimer Holdings, Inc.. They currently have a $35.00 price target on the stock.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) had its hold rating reiterated by analysts at Maxim Group. They currently have a $15.50 target price on the stock.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) had its neutral rating reiterated by analysts at UBS AG. UBS AG currently has a $19.00 price target on the stock.

Target Corporation (NYSE:TGT) had its market weight rating reissued by analysts at BMO Capital Markets.

Tourmaline Oil Corp (TSE:TOU) had its outperform rating reaffirmed by analysts at Macquarie. Macquarie currently has a C$40.00 target price on the stock.

Tesla (NASDAQ:TSLA) had its market perform rating reissued by analysts at Sanford C. Bernstein. The firm currently has a $265.00 target price on the stock.

Seven Generations Energy (TSE:VII) had its outperform rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a C$27.00 price target on the stock.

Western Digital Corporation (NASDAQ:WDC) had its buy rating reaffirmed by analysts at Longbow Research. Longbow Research currently has a $120.00 price target on the stock.

Wal-Mart Stores (NYSE:WMT) had its market weight rating reissued by analysts at BMO Capital Markets.

Receive News & Ratings for Applied Genetic Technologies Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Genetic Technologies Corporation and related companies with MarketBeat.com's FREE daily email newsletter.